<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="systematic-review" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title>Frontiers in Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnins.2024.1474780</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Systematic Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Predictive value of radiomics for intracranial aneurysm rupture: a systematic review and meta-analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Haoda</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Xu</surname> <given-names>Haidong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Fan</surname> <given-names>Junsheng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname> <given-names>Jie</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Liangfu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Kong</surname> <given-names>Zailiang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhao</surname> <given-names>Hui</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2807538/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Radiology, The First Hospital of Huhhot</institution>, <addr-line>Huhhot</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Radiotherapy, Affiliated Hospital of Inner Mongolia Medical University</institution>, <addr-line>Huhhot</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001">
<p>Edited by: Mario Sansone, University of Naples Federico II, Italy</p>
</fn>
<fn fn-type="edited-by" id="fn0002">
<p>Reviewed by: Roberta Fusco, IGEA (Italy), Italy</p>
<p>Marika Valentino, National Research Council (CNR), Italy</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Hui Zhao, <email>zhaohui1205@outlook.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>10</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>18</volume>
<elocation-id>1474780</elocation-id>
<history>
<date date-type="received">
<day>02</day>
<month>08</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>09</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Wang, Xu, Fan, Liu, Li, Kong and Zhao.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Wang, Xu, Fan, Liu, Li, Kong and Zhao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Objective</title>
<p>To systematically review the literature on radiomics for predicting intracranial aneurysm rupture and conduct a meta-analysis to obtain evidence confirming the value of radiomics in this prediction.</p>
</sec>
<sec id="sec2">
<title>Methods</title>
<p>A systematic literature search was conducted in PubMed, Web of Science, Embase, and The Cochrane Library databases up to March 2024. The QUADAS-2 tool was used to assess study quality. Stata 15.0 and Review Manager 5.4.1 were used for statistical analysis. Outcomes included combined sensitivity (Sen), specificity (Spe), positive likelihood ratio (+LR), negative likelihood ratio (&#x2212;LR), diagnostic odds ratio (DOR), and their 95% confidence intervals (CI), as well as pre-test and post-test probabilities. The SROC curve was plotted, and the area under the curve (AUC) was calculated. Publication bias and small-study effects were assessed using the Deeks&#x2019; funnel plot.</p>
</sec>
<sec id="sec3">
<title>Results</title>
<p>The 9 included studies reported 4,284 patients, with 1,411 patients with intracranial aneurysm rupture (prevalence 32.9%). The overall performance of radiomics for predicting intracranial aneurysm rupture showed a combined Sen of 0.78 (95% CI: 0.74&#x2013;0.82), Spe of 0.74 (95% CI: 0.70&#x2013;0.78), +LR of 3.0 (95% CI: 2.7&#x2013;3.4), &#x2212;LR of 0.29 (95% CI: 0.25&#x2013;0.35), DOR of 10 (95% CI: 9&#x2013;12), and AUC of 0.83 (95% CI: 0.79&#x2013;0.86). Significant heterogeneity was observed in both Sen (I<sup>2</sup> =&#x2009;90.93, 95% CI: 89.00&#x2013;92.87%) and Spe (I<sup>2</sup> =&#x2009;94.28, 95% CI: 93.21&#x2013;95.34%).</p>
</sec>
<sec id="sec4">
<title>Conclusion</title>
<p>Radiomics can improve the diagnostic efficacy of intracranial aneurysm rupture. More large-sample, prospective, multicenter clinical studies are needed to further evaluate its predictive value.</p>
</sec>
<sec id="sec579">
<title>Systematic review registration</title>
<p><ext-link xlink:href="https://www.crd.york.ac.uk/PROSPERO/" ext-link-type="uri">https://www.crd.york.ac.uk/PROSPERO/</ext-link>.</p>
</sec>
</abstract>
<kwd-group>
<kwd>radiomics</kwd>
<kwd>intracranial aneurysm rupture</kwd>
<kwd>meta-analysis</kwd>
<kwd>systematic review</kwd>
<kwd>diagnosis</kwd>
</kwd-group>
<counts>
<fig-count count="7"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="38"/>
<page-count count="15"/>
<word-count count="7056"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Brain Imaging Methods</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec5">
<label>1</label>
<title>Introduction</title>
<p>Intracranial aneurysm is a tumor-like protrusion formed when the lumen of an intracranial artery gradually expands and bulges due to localized damage to the arterial wall caused by congenital developmental abnormalities or acquired injuries, under the influence of hemodynamic load or other factors (<xref ref-type="bibr" rid="ref7">Etminan and Rinkel, 2016</xref>). With the development of imaging technology, the detection rate of unruptured intracranial aneurysms is increasing annually (<xref ref-type="bibr" rid="ref10">Greving et al., 2014</xref>). However, the treatment decision for unruptured intracranial aneurysms remains controversial. Many intracranial aneurysms are asymptomatic and do not rupture for an extended period (<xref ref-type="bibr" rid="ref13">Korja et al., 2014</xref>). Currently, preventive treatment for unruptured intracranial aneurysms includes endovascular treatment and neurosurgical interventional treatment, both associated with the inevitable risk of treatment-related complications (<xref ref-type="bibr" rid="ref19">Naggara et al., 2010</xref>; <xref ref-type="bibr" rid="ref37">Zhu et al., 2020</xref>). Conversely, once an intracranial aneurysm ruptures, it leads to subarachnoid hemorrhage (SAH), a severe subtype of stroke often accompanied by high mortality and disability rates (<xref ref-type="bibr" rid="ref28">Vlak et al., 2011</xref>). Therefore, early screening of patients with intracranial aneurysms at high risk of rupture and providing them with timely preventive treatment are crucial for improving patient prognosis.</p>
<p>Previous studies have demonstrated that the risk of intracranial aneurysm rupture is associated with its morphological characteristics (<xref ref-type="bibr" rid="ref15">Lindgren et al., 2016</xref>). Researchers have measured and defined these characteristics, such as neck width, aneurysm angle, and height, on computed tomographic angiography (CTA) or digital subtraction angiography (DSA) images of intracranial aneurysms (<xref ref-type="bibr" rid="ref32">Zhang et al., 2019</xref>; <xref ref-type="bibr" rid="ref3">Chen et al., 2020</xref>). Radiomics, a new computer-assisted technology, extracts quantitative features (e.g., shape, intensity, and texture) from biomedical images in an objective, reproducible, and high-throughput manner (<xref ref-type="bibr" rid="ref34">Zhou et al., 2018</xref>; <xref ref-type="bibr" rid="ref11">Hua et al., 2020</xref>; <xref ref-type="bibr" rid="ref26">Tomaszewski and Gillies, 2021</xref>). The principle is that pathophysiological changes of certain diseases are manifested in digital medical images, and radiomics can extract this information through quantitative analysis and subsequent biological information mining (<xref ref-type="bibr" rid="ref9">Gillies et al., 2016</xref>). Recently, the application of radiomics in cerebrovascular diseases has increased (<xref ref-type="bibr" rid="ref4">Chen et al., 2021</xref>; <xref ref-type="bibr" rid="ref35">Zhu et al., 2021</xref>; <xref ref-type="bibr" rid="ref38">Zhu et al., 2021</xref>). Some studies have demonstrated an association between radiomics characteristics of aneurysms and the risk of intracranial aneurysm rupture (<xref ref-type="bibr" rid="ref16">Liu et al., 2019</xref>; <xref ref-type="bibr" rid="ref21">Ou et al., 2021</xref>). However, these studies did not analyze the stability of the imaging features, which can be affected by differences in scanning parameters or image segmentation methods (<xref ref-type="bibr" rid="ref18">Mackin et al., 2015</xref>; <xref ref-type="bibr" rid="ref5">Choe et al., 2019</xref>). Furthermore, most previous studies on imaging features of intracranial aneurysms have not been validated by external datasets, leaving the reproducibility and generalizability of their results uncertain (<xref ref-type="bibr" rid="ref36">Zhu et al., 2021</xref>; <xref ref-type="bibr" rid="ref17">Luo et al., 2023</xref>; <xref ref-type="bibr" rid="ref27">Turhon et al., 2023</xref>).</p>
<p>Recently, the rapid development of computer science, particularly the progress of artificial intelligence, has led to algorithms such as machine learning and deep learning playing an increasingly important role in medical data processing (<xref ref-type="bibr" rid="ref4">Chen et al., 2021</xref>). Algorithms, including support vector machines, random forests, and artificial neural networks, have been successfully applied to disease diagnosis, metastasis prediction, and treatment prognosis evaluation (<xref ref-type="bibr" rid="ref20">Orru et al., 2012</xref>; <xref ref-type="bibr" rid="ref2">Beig et al., 2019</xref>; <xref ref-type="bibr" rid="ref12">Khorrami et al., 2019</xref>). Appropriate algorithms can maximize the mining of data information and assist in disease diagnosis. To date, many radiomic models have been used to predict ruptured intracranial aneurysms. However, no relevant meta-analysis has been reported, and its sensitivity and specificity remain undetermined. Therefore, this study systematically searched Pubmed, Embase, Cochrane and Web of Science to obtain all literatures on radiomics in predicting intracranial aneurysm rupture, and conducted a meta-analysis for the first time to obtain the latest and most comprehensive evidence-based confirmation of the value of radiomics in predicting intracranial aneurysm rupture.</p>
</sec>
<sec sec-type="methods" id="sec6">
<label>2</label>
<title>Methods</title>
<sec id="sec7">
<label>2.1</label>
<title>Protocol and registration</title>
<p>This systematic review and meta-analysis, prospectively registered in PROSPERO (CRD42024453092), was performed following the PRISMA 2020 statement (<xref ref-type="bibr" rid="ref23">Page et al., 2021</xref>).</p>
</sec>
<sec id="sec8">
<label>2.2</label>
<title>Search strategy</title>
<p>A systematic literature search was conducted in PubMed, Web of Science, Embase, and The Cochrane Library databases using medical subject headings and free words, including &#x201C;radiomics,&#x201D; &#x201C;aneurysm,&#x201D; &#x201C;rupture,&#x201D; and &#x201C;intracranial.&#x201D; The search strategies for PubMed were as follows: ((&#x201C;Intracranial Aneurysm&#x201D;[Mesh]) OR (((((((((((((((((((((((((((((((((((((Aneurysms, Intracranial) OR (Intracranial Aneurysms)) OR (Aneurysm, Intracranial)) OR (Aneurysm, Anterior Communicating Artery)) OR (Anterior Communicating Artery Aneurysm)) OR (Aneurysm, Basilar Artery)) OR (Aneurysms, Basilar Artery)) OR (Artery Aneurysm, Basilar)) OR (Artery Aneurysms, Basilar)) OR (Basilar Artery Aneurysms)) OR (Basilar Artery Aneurysm)) OR (Aneurysm, Middle Cerebral Artery)) OR (Middle Cerebral Artery Aneurysm)) OR (Aneurysm, Posterior Cerebral Artery)) OR (Posterior Cerebral Artery Aneurysm)) OR (Berry Aneurysm)) OR (Aneurysm, Berry)) OR (Aneurysms, Berry)) OR (Berry Aneurysms)) OR (Brain Aneurysm)) OR (Aneurysm, Brain)) OR (Aneurysms, Brain)) OR (Brain Aneurysms)) OR (Cerebral Aneurysm)) OR (Aneurysms, Cerebral)) OR (Cerebral Aneurysms)) OR (Aneurysm, Cerebral)) OR (Giant Intracranial Aneurysm)) OR (Aneurysm, Giant Intracranial)) OR (Aneurysms, Giant Intracranial)) OR (Giant Intracranial Aneurysms)) OR (Intracranial Aneurysm, Giant)) OR (Intracranial Aneurysms, Giant)) OR (Aneurysm, Anterior Cerebral Artery)) OR (Anterior Cerebral Artery Aneurysm)) OR (Aneurysm, Posterior Communicating Artery)) OR (Posterior Communicating Artery Aneurysm))) AND (((radiomic&#x002A;) OR (Histogram&#x002A;)) OR (Texture&#x002A;)). The search time was up to March, 2024. Furthermore, we manually screened the bibliography lists of all included studies. Two authors retrieved and assessed eligible articles independently. Any differences in literature retrieval were resolved by discussion. All retrieved literature was manually reviewed and verified through EndNote X9.</p>
</sec>
<sec id="sec9">
<label>2.3</label>
<title>Inclusion and exclusion criteria</title>
<p>This study included prospective and retrospective studies investigating the predictive value of radiomics for intracranial aneurysm rupture. Inclusion criteria:</p>
<p>P: patients with suspected or confirmed ruptured intracranial aneurysms.</p>
<p>I: radiomics as the evaluated experiment, regardless of model and method.</p>
<p>C: gold standard, including CTA, MRA, or DSA.</p>
<p>O: sensitivity (Sen), specificity (Spe), positive likelihood ratio (+LR), negative likelihood ratio (&#x2212;LR), diagnostic odds ratio (DOR), pre-test probability, post-test probability, summary receiver operating characteristic (SROC) area under the curve (AUC).</p>
<p>S: prospective and retrospective studies focusing on the predictive value of radiomics for intracranial aneurysm rupture.</p>
<p>Exclusion criteria: (<xref ref-type="bibr" rid="ref7">Etminan and Rinkel, 2016</xref>) duplicate publications; (<xref ref-type="bibr" rid="ref10">Greving et al., 2014</xref>) irrelevant articles; (<xref ref-type="bibr" rid="ref13">Korja et al., 2014</xref>) reviews, meta-analyses, conferences, letters, comments; (<xref ref-type="bibr" rid="ref19">Naggara et al., 2010</xref>) animal models, studies with low sample size; (<xref ref-type="bibr" rid="ref37">Zhu et al., 2020</xref>) articles with no or incomplete data; (<xref ref-type="bibr" rid="ref28">Vlak et al., 2011</xref>) non-English articles.</p>
</sec>
<sec id="sec10">
<label>2.4</label>
<title>Data extraction</title>
<p>Two independent reviewers extracted data from eligible studies, including first author, publication year, study design, subjects&#x2019; age, gender, radiomics models, gold standard, sample size of case and control groups, true positives (TP), false positives (FP), true negatives (TN), false negatives (FN), Sen, Spe, +LR, &#x2212;LR, DOR, pre-test probability, post-test probability, and AUC value. Disagreements between the two reviewers were resolved by consulting a third party. Corresponding authors were contacted for full data if research data was insufficient. All data were summarized in a Microsoft Excel spreadsheet.</p>
</sec>
<sec id="sec11">
<label>2.5</label>
<title>Quality assessment</title>
<p>The quality assessment of the included literature was conducted using the QUADAS-2 tool, following the guidelines in the Cochrane Handbook for systematic reviews of diagnostic trials. The final evaluation findings were presented using the Review Manager 5.4.1 software (<xref ref-type="bibr" rid="ref24">Qu et al., 2018</xref>). Two reviewers independently assessed the literature quality, with disagreements resolved through discussion or adjudication by a third reviewer when necessary. The QUADAS-2 tool assesses literature quality from two aspects: risk of bias and clinical applicability. The risk of bias comprises four aspects: patient selection, index test, reference standard, and flow and timing. The clinical applicability questions consist of three aspects: patient selection, index test, and reference standard. Each evaluation domain in the risk of bias contains signaling questions with &#x201C;yes/no/unclear&#x201D; answer options. If all signaling questions in a domain are answered &#x201C;yes,&#x201D; the risk of bias in that aspect is considered low. If one answer is &#x201C;no,&#x201D; there is a possibility of bias. Clinical applicability has no signaling questions, only an overall assessment with &#x201C;high risk/low risk/unclear&#x201D; answer options. The &#x201C;unclear&#x201D; option can only be selected when the literature provides incomplete information during the assessment process. In addition, the Radiomics Quality Score (RQS) was used to assess the characteristics and quality of each included radiomics study. This scoring scale has 36 potential scores based on 16 criteria, with 36 indicating the highest quality (<xref ref-type="bibr" rid="ref25">Spadarella et al., 2023</xref>).</p>
</sec>
<sec id="sec12">
<label>2.6</label>
<title>Data analysis</title>
<p>Stata 15.0 and Review Manager 5.4.1 software were used for statistical analysis. A bivariate mixed-effects regression model was employed after the random-effects model to combine Sen, Spe, +LR, &#x2212;LR, DOR, and their 95% confidence intervals (95% CI), as well as pre-test and post-test probabilities. The SROC curve was plotted, and the AUC was calculated. The <italic>&#x03C7;</italic><sup>2</sup> test, with a test level of <italic>&#x03B1;</italic>&#x2009;=&#x2009;0.05, was used to analyze the statistical heterogeneity among studies, and the <italic>I</italic><sup>2</sup> value quantitatively determined the heterogeneity. An I<sup>2</sup> &#x2264;&#x2009;50% indicated low heterogeneity, while a higher value suggested high heterogeneity. The Deeks&#x2019; funnel plot assessed publication bias and assumed small-study effects, with <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05 indicating publication bias in the included literature. When publication bias is present, the trim-and-fill method is used to assess the effect of the bias on the combined statistics (<xref ref-type="bibr" rid="ref33">Zhang and Zhong, 2008</xref>).</p>
</sec>
</sec>
<sec sec-type="results" id="sec13">
<label>3</label>
<title>Results</title>
<sec id="sec14">
<label>3.1</label>
<title>Literature screening process and results</title>
<p>A total of 248 articles were obtained using the literature search strategy. After removing duplicates using EndNote X9, 156 articles remained. Following the exclusion of 138 articles based on titles and abstracts, 18 articles underwent initial screening. Among these, 9 articles were further excluded after full-text review due to incomplete information and not meeting the requirements, resulting in a final inclusion of 9 articles (<xref ref-type="bibr" rid="ref21">Ou et al., 2021</xref>; <xref ref-type="bibr" rid="ref1">Alwalid et al., 2021</xref>; <xref ref-type="bibr" rid="ref36">Zhu et al., 2021</xref>; <xref ref-type="bibr" rid="ref14">Li et al., 2022</xref>; <xref ref-type="bibr" rid="ref22">Ou et al., 2022</xref>; <xref ref-type="bibr" rid="ref30">Yamanouchi et al., 2022</xref>; <xref ref-type="bibr" rid="ref17">Luo et al., 2023</xref>; <xref ref-type="bibr" rid="ref27">Turhon et al., 2023</xref>; <xref ref-type="bibr" rid="ref31">Yang et al., 2023</xref>). <xref ref-type="fig" rid="fig1">Figure 1</xref> illustrates the literature screening process flowchart, and <xref ref-type="table" rid="tab1">Table 1</xref> presents the fundamental characteristics of the included studies. For studies with multiple models or cohorts, separate extraction was performed, distinguished by adding the letters &#x201C;a, b, c, or d&#x201D; after the study names.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>PRISMA flow-chart for the systematic review and meta-analysis.</p>
</caption>
<graphic xlink:href="fnins-18-1474780-g001.tif"/>
</fig>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Characteristic of included studies.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Author</th>
<th align="center" valign="top">Year</th>
<th align="left" valign="top">Cohort</th>
<th align="left" valign="top">Region</th>
<th align="left" valign="top">Study design</th>
<th align="left" valign="top">Population</th>
<th align="left" valign="top">Feature extraction soft</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Alwalid</td>
<td align="center" valign="top">2021a</td>
<td align="left" valign="top">Training</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Prospective/retrospective</td>
<td align="left" valign="top">(1) Adult patient over 18&#x2009;years old and (2) a diagnosis of intracranial aneurysm on CT angiography regardless of the rupture status of the aneurysm.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Alwalid</td>
<td align="center" valign="top">2021b</td>
<td align="left" valign="top">Test</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Prospective/retrospective</td>
<td align="left" valign="top">(1) Adult patient over 18&#x2009;years old and (2) a diagnosis of intracranial aneurysm on CT angiography regardless of the rupture status of the aneurysm.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Li</td>
<td align="center" valign="top">2022a</td>
<td align="left" valign="top">training</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Prospective</td>
<td align="left" valign="top">(1) confirmed diagnosis of one or more unruptured saccular cerebral aneurysms at baseline by CTA (positive diagnosis in the clinical record by experienced radiologist); (2) aneurysm maximum diameter&#x2009;&#x003E;&#x2009;2&#x2009;mm and lesion morphology that is differentiable from infundibulum; (3) image quality allowed detailed depiction of aneurysm morphology and parent vessels, and was sufficient for the segmentation without substantial artifacts.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Li</td>
<td align="center" valign="top">2022b</td>
<td align="left" valign="top">test</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Prospective</td>
<td align="left" valign="top">(1) confirmed diagnosis of one or more unruptured saccular cerebral aneurysms at baseline by CTA (positive diagnosis in the clinical record by experienced radiologist); (2) aneurysm maximum diameter&#x2009;&#x003E;&#x2009;2&#x2009;mm and lesion morphology that is differentiable from infundibulum; (3) image quality allowed detailed depiction of aneurysm morphology and parent vessels, and was sufficient for the segmentation without substantial artifacts.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Li</td>
<td align="center" valign="top">2022c</td>
<td align="left" valign="top">training</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Prospective</td>
<td align="left" valign="top">(1) confirmed diagnosis of one or more unruptured saccular cerebral aneurysms at baseline by CTA (positive diagnosis in the clinical record by experienced radiologist); (2) aneurysm maximum diameter&#x2009;&#x003E;&#x2009;2&#x2009;mm and lesion morphology that is differentiable from infundibulum; (3) image quality allowed detailed depiction of aneurysm morphology and parent vessels, and was sufficient for the segmentation without substantial artifacts.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Li</td>
<td align="center" valign="top">2022d</td>
<td align="left" valign="top">test</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Prospective</td>
<td align="left" valign="top">(1) confirmed diagnosis of one or more unruptured saccular cerebral aneurysms at baseline by CTA (positive diagnosis in the clinical record by experienced radiologist); (2) aneurysm maximum diameter&#x2009;&#x003E;&#x2009;2&#x2009;mm and lesion morphology that is differentiable from infundibulum; (3) image quality allowed detailed depiction of aneurysm morphology and parent vessels, and was sufficient for the segmentation without substantial artifacts.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Luo</td>
<td align="center" valign="top">2023a</td>
<td align="left" valign="top">Internal</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">(1) ruptured or unruptured saccular CAs located in the anterior circulation arteries and, the subarachnoid hemorrhage can be explicitly attributed to aneurysm rupture; (2) a minimum aneurysm diameter&#x2009;&#x003E;&#x2009;3&#x2009;mm; and (3) good- quality cerebrovascular imaging&#x2014;CTA or MRA data&#x2014;that can adequately be used to reconstruct the aneurysm and 3&#x2013;5&#x2009;mm of its adjacent parent arteries with clear boundaries.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Luo</td>
<td align="center" valign="top">2023b</td>
<td align="left" valign="top">Internal</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">(1) ruptured or unruptured saccular CAs located in the anterior circulation arteries and, the subarachnoid hemorrhage can be explicitly attributed to aneurysm rupture; (2) a minimum aneurysm diameter&#x2009;&#x003E;&#x2009;3&#x2009;mm; and (3) good- quality cerebrovascular imaging&#x2014;CTA or MRA data&#x2014;that can adequately be used to reconstruct the aneurysm and 3&#x2013;5&#x2009;mm of its adjacent parent arteries with clear boundaries.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Luo</td>
<td align="center" valign="top">2023c</td>
<td align="left" valign="top">Internal</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">(1) ruptured or unruptured saccular CAs located in the anterior circulation arteries and, the subarachnoid hemorrhage can be explicitly attributed to aneurysm rupture; (2) a minimum aneurysm diameter&#x2009;&#x003E;&#x2009;3&#x2009;mm; and (3) good- quality cerebrovascular imaging&#x2014;CTA or MRA data&#x2014;that can adequately be used to reconstruct the aneurysm and 3&#x2013;6&#x2009;mm of its adjacent parent arteries with clear boundaries.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Luo</td>
<td align="center" valign="top">2023d</td>
<td align="left" valign="top">External</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">(1) ruptured or unruptured saccular CAs located in the anterior circulation arteries and, the subarachnoid hemorrhage can be explicitly attributed to aneurysm rupture; (2) a minimum aneurysm diameter&#x2009;&#x003E;&#x2009;3&#x2009;mm; and (3) good- quality cerebrovascular imaging&#x2014;CTA or MRA data&#x2014;that can adequately be used to reconstruct the aneurysm and 3&#x2013;7&#x2009;mm of its adjacent parent arteries with clear boundaries.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Luo</td>
<td align="center" valign="top">2023e</td>
<td align="left" valign="top">External</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">(1) ruptured or unruptured saccular CAs located in the anterior circulation arteries and, the subarachnoid hemorrhage can be explicitly attributed to aneurysm rupture; (2) a minimum aneurysm diameter&#x2009;&#x003E;&#x2009;3&#x2009;mm; and (3) good- quality cerebrovascular imaging&#x2014;CTA or MRA data&#x2014;that can adequately be used to reconstruct the aneurysm and 3&#x2013;8&#x2009;mm of its adjacent parent arteries with clear boundaries.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Luo</td>
<td align="center" valign="top">2023f</td>
<td align="left" valign="top">External</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">(1) ruptured or unruptured saccular CAs located in the anterior circulation arteries and, the subarachnoid hemorrhage can be explicitly attributed to aneurysm rupture; (2) a minimum aneurysm diameter&#x2009;&#x003E;&#x2009;3&#x2009;mm; and (3) good- quality cerebrovascular imaging&#x2014;CTA or MRA data&#x2014;that can adequately be used to reconstruct the aneurysm and 3&#x2013;9&#x2009;mm of its adjacent parent arteries with clear boundaries.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Ou</td>
<td align="center" valign="top">2021a</td>
<td/>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Prospective</td>
<td align="left" valign="top">A confirmed diagnosis of one or more intracranial aneurysms</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Ou</td>
<td align="center" valign="top">2021b</td>
<td/>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Prospective</td>
<td align="left" valign="top">A confirmed diagnosis of one or more intracranial aneurysms</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Ou</td>
<td align="center" valign="top">2022</td>
<td/>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">A confirmed diagnosis of one or more intracranial aneurysms</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="center" valign="top">2023a</td>
<td align="left" valign="top">Trainin</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">(1) at least one intracranial aneurysm confirmed by digital subtraction angiography (DSA) imaging; (2) older than 18&#x2009;years; and (3) accessibility of morphological and radiomics data.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="center" valign="top">2023b</td>
<td align="left" valign="top">Trainin</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">(1) at least one intracranial aneurysm confirmed by digital subtraction angiography (DSA) imaging; (2) older than 18&#x2009;years; and (4) accessibility of morphological and radiomics data.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="center" valign="top">2023c</td>
<td align="left" valign="top">Trainin</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">(1) at least one intracranial aneurysm confirmed by digital subtraction angiography (DSA) imaging; (2) older than 18&#x2009;years; and (5) accessibility of morphological and radiomics data.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="center" valign="top">2023d</td>
<td align="left" valign="top">Internal validatio</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">(1) at least one intracranial aneurysm confirmed by digital subtraction angiography (DSA) imaging; (2) older than 18&#x2009;years; and (6) accessibility of morphological and radiomics data.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="center" valign="top">2023e</td>
<td align="left" valign="top">Internal validatio</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">(1) at least one intracranial aneurysm confirmed by digital subtraction angiography (DSA) imaging; (2) older than 18&#x2009;years; and (7) accessibility of morphological and radiomics data.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="center" valign="top">2023f</td>
<td align="left" valign="top">Internal validatio</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">(1) at least one intracranial aneurysm confirmed by digital subtraction angiography (DSA) imaging; (2) older than 18&#x2009;years; and (8) accessibility of morphological and radiomics data.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="center" valign="top">2023&#x2009;g</td>
<td align="left" valign="top">External validation</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">(1) at least one intracranial aneurysm confirmed by digital subtraction angiography (DSA) imaging; (2) older than 18&#x2009;years; and (9) accessibility of morphological and radiomics data.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="center" valign="top">2023&#x2009;h</td>
<td align="left" valign="top">External validation</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">(1) at least one intracranial aneurysm confirmed by digital subtraction angiography (DSA) imaging; (2) older than 18&#x2009;years; and (10) accessibility of morphological and radiomics data.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="center" valign="top">2023i</td>
<td align="left" valign="top">External validation</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">(1) at least one intracranial aneurysm confirmed by digital subtraction angiography (DSA) imaging; (2) older than 18&#x2009;years; and (11) accessibility of morphological and radiomics data.</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Yamanouchi</td>
<td align="center" valign="top">2022</td>
<td align="left" valign="top">Test</td>
<td align="left" valign="top">Japan</td>
<td align="left" valign="top">Prospective</td>
<td align="left" valign="top">Patients who underwent MRA for intracranial aneurysms examination</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="center" valign="top">2023a</td>
<td align="left" valign="top">Validation</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">Patients diagnosed with intracranial aneurysms by CTA or digital subtraction angiography (DSA)</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="center" valign="top">2023b</td>
<td align="left" valign="top">Validation</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">Patients diagnosed with intracranial aneurysms by CTA or digital subtraction angiography (DSA)</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="center" valign="top">2023c</td>
<td align="left" valign="top">Validation</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">Patients diagnosed with intracranial aneurysms by CTA or digital subtraction angiography (DSA)</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="center" valign="top">2023d</td>
<td align="left" valign="top">Validation</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">Patients diagnosed with intracranial aneurysms by CTA or digital subtraction angiography (DSA)</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="center" valign="top">2023e</td>
<td align="left" valign="top">Validation</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">Patients diagnosed with intracranial aneurysms by CTA or digital subtraction angiography (DSA)</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="center" valign="top">2023f</td>
<td align="left" valign="top">Validation</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">Patients diagnosed with intracranial aneurysms by CTA or digital subtraction angiography (DSA)</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="center" valign="top">2023&#x2009;g</td>
<td align="left" valign="top">Validation</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">Patients diagnosed with intracranial aneurysms by CTA or digital subtraction angiography (DSA)</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="center" valign="top">2023&#x2009;h</td>
<td align="left" valign="top">Validation</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">Patients diagnosed with intracranial aneurysms by CTA or digital subtraction angiography (DSA)</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="center" valign="top">2023i</td>
<td align="left" valign="top">Validation</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">Patients diagnosed with intracranial aneurysms by CTA or digital subtraction angiography (DSA)</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="center" valign="top">2023j</td>
<td align="left" valign="top">Validation</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">Patients diagnosed with intracranial aneurysms by CTA or digital subtraction angiography (DSA)</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="center" valign="top">2023&#x2009;k</td>
<td align="left" valign="top">Validation</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">Patients diagnosed with intracranial aneurysms by CTA or digital subtraction angiography (DSA)</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="center" valign="top">2023&#x2009;L</td>
<td align="left" valign="top">Validation</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">Patients diagnosed with intracranial aneurysms by CTA or digital subtraction angiography (DSA)</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="center" valign="top">2021a</td>
<td align="left" valign="top">Training</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">MCA aneurysms with available computed tomography angiography (CTA) data were included</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="center" valign="top">2021b</td>
<td align="left" valign="top">Training</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">MCA aneurysms with available computed tomography angiography (CTA) data were included</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="center" valign="top">2021c</td>
<td align="left" valign="top">Training</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">MCA aneurysms with available computed tomography angiography (CTA) data were included</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="center" valign="top">2021d</td>
<td align="left" valign="top">Temporal validation dataset</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">MCA aneurysms with available computed tomography angiography (CTA) data were included</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="center" valign="top">2021e</td>
<td align="left" valign="top">Temporal validation dataset</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">MCA aneurysms with available computed tomography angiography (CTA) data were included</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="center" valign="top">2021f</td>
<td align="left" valign="top">Temporal validation dataset</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">MCA aneurysms with available computed tomography angiography (CTA) data were included</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="center" valign="top">2021&#x2009;g</td>
<td align="left" valign="top">External validation dataset</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">MCA aneurysms with available computed tomography angiography (CTA) data were included</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="center" valign="top">2021&#x2009;h</td>
<td align="left" valign="top">External validation dataset</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">MCA aneurysms with available computed tomography angiography (CTA) data were included</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="center" valign="top">2021i</td>
<td align="left" valign="top">External validation dataset</td>
<td align="left" valign="top">China</td>
<td align="left" valign="top">Retrospective</td>
<td align="left" valign="top">MCA aneurysms with available computed tomography angiography (CTA) data were included</td>
<td align="left" valign="top">Pyradiomics package</td>
</tr>
</tbody>
</table>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top" rowspan="3">Author</th>
<th align="left" valign="top" rowspan="3">Model (Machinelearning)</th>
<th align="left" valign="top" rowspan="3">Imaging omics</th>
<th align="left" valign="top" rowspan="3">Gold standard</th>
<th align="center" valign="top" colspan="6">Clinic patient information</th>
</tr>
<tr>
<th align="center" valign="top" colspan="2">Patients</th>
<th align="center" valign="top" colspan="2">Age</th>
<th align="center" valign="top" colspan="2">Gender</th>
</tr>
<tr>
<th align="center" valign="top">Positive</th>
<th align="center" valign="top">Negative</th>
<th align="center" valign="top">Ruptured</th>
<th align="center" valign="top">Unruptured</th>
<th align="center" valign="top">Male</th>
<th align="center" valign="top">Female</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Alwalid</td>
<td align="left" valign="top">LR</td>
<td align="left" valign="top">1.Wavelet-HHL.firstorder.Entropy, 2.LBP-3D-m1.firstorder.90Percentile, 3.LBP-3D-m2.firstorder.Skewness, 4.LoG-sigma-20&#x2009;mm-3D.GLCM.ID, 5.LoG-sigma-20&#x2009;mm-3D.GLSZM.SmallAreaHighGrayLevelEmphasis, 6.LoG-sigma-30&#x2009;mm-3D.GLCM.InverseVariance, 7.Wavelet-LHH.firstorder.RootMeanSquared, 8.Wavelet-LHL.firstorder.Median, 9.Wavelet-LLH.GLDM.SmallDependenceEmphasis</td>
<td align="left" valign="top">1.spontaneous subarachnoid hemorrhage, 2.CTA, 3.DSA</td>
<td align="center" valign="top">152</td>
<td align="center" valign="top">241</td>
<td align="center" valign="top">55&#x2009;&#x00B1;&#x2009;9</td>
<td align="center" valign="top">57&#x2009;&#x00B1;&#x2009;11</td>
<td align="center" valign="top">159</td>
<td align="center" valign="top">234</td>
</tr>
<tr>
<td align="left" valign="top">Alwalid</td>
<td align="left" valign="top">LR</td>
<td align="left" valign="top">1.Wavelet-HHL.firstorder.Entropy, 2.LBP-3D-m1.firstorder.90Percentile, 3.LBP-3D-m2.firstorder.Skewness, 4.LoG-sigma-20&#x2009;mm-3D.GLCM.ID, 5.LoG-sigma-20&#x2009;mm-3D.GLSZM.SmallAreaHighGrayLevelEmphasis, 6.LoG-sigma-30&#x2009;mm-3D.GLCM.InverseVariance, 7.Wavelet-LHH.firstorder.RootMeanSquared, 8.Wavelet-LHL.firstorder.Median, 10.Wavelet-LLH.GLDM.SmallDependenceEmphasis</td>
<td align="left" valign="top">1.spontaneous subarachnoid hemorrhage, 2.CTA, 3.DSA</td>
<td align="center" valign="top">152</td>
<td align="center" valign="top">241</td>
<td align="center" valign="top">55&#x2009;&#x00B1;&#x2009;9</td>
<td align="center" valign="top">57&#x2009;&#x00B1;&#x2009;11</td>
<td align="center" valign="top">159</td>
<td align="center" valign="top">234</td>
</tr>
<tr>
<td align="left" valign="top">Li</td>
<td align="left" valign="top">Radiomics derived features</td>
<td align="left" valign="top">wavelet.HLL_glcm_Correlation wavelet.HLH_glszm_SizeZoneNonUniformityNormalized original_glszm_SmallAreaLowGrayLevelEmphasis wavelet.HLL_glszm_GrayLevelNonUniformity wavelet.LHL_firstorder_Median wavelet.HHL_gldm_LargeDependenceHighGrayLevelEmphasis</td>
<td align="left" valign="top">CTA</td>
<td align="center" valign="top">11</td>
<td align="center" valign="top">216</td>
<td align="center" valign="top">61 (49&#x2013;68)</td>
<td align="center" valign="top">78</td>
<td align="center" valign="top">149</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Li</td>
<td align="left" valign="top">Radiomics derived features</td>
<td align="left" valign="top">wavelet.HLL_glcm_Correlation wavelet.HLH_glszm_SizeZoneNonUniformityNormalized original_glszm_SmallAreaLowGrayLevelEmphasis wavelet.HLL_glszm_GrayLevelNonUniformity wavelet.LHL_firstorder_Median wavelet.HHL_gldm_LargeDependenceHighGrayLevelEmphasis</td>
<td align="left" valign="top">CTA</td>
<td align="center" valign="top">11</td>
<td align="center" valign="top">216</td>
<td align="center" valign="top">61 (49&#x2013;68)</td>
<td align="center" valign="top">78</td>
<td align="center" valign="top">149</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Li</td>
<td align="left" valign="top">Radiomics derived morphological features</td>
<td align="left" valign="top">wavelet.HLL_glcm_Correlation wavelet.HLH_glszm_SizeZoneNonUniformityNormalized original_glszm_SmallAreaLowGrayLevelEmphasis wavelet.HLL_glszm_GrayLevelNonUniformity wavelet.LHL_firstorder_Median wavelet.HHL_gldm_LargeDependenceHighGrayLevelEmphasis</td>
<td align="left" valign="top">CTA</td>
<td align="center" valign="top">11</td>
<td align="center" valign="top">216</td>
<td align="center" valign="top">61 (49&#x2013;68)</td>
<td align="center" valign="top">78</td>
<td align="center" valign="top">149</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Li</td>
<td align="left" valign="top">Radiomics derived morphological features</td>
<td align="left" valign="top">wavelet.HLL_glcm_Correlation wavelet.HLH_glszm_SizeZoneNonUniformityNormalized original_glszm_SmallAreaLowGrayLevelEmphasis wavelet.HLL_glszm_GrayLevelNonUniformity wavelet.LHL_firstorder_Median wavelet.HHL_gldm_LargeDependenceHighGrayLevelEmphasis</td>
<td align="left" valign="top">CTA</td>
<td align="center" valign="top">11</td>
<td align="center" valign="top">216</td>
<td align="center" valign="top">61 (49&#x2013;68)</td>
<td align="center" valign="top">78</td>
<td align="center" valign="top">149</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Luo</td>
<td align="left" valign="top">Ridge regression</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA and MRA</td>
<td align="center" valign="top">148</td>
<td align="center" valign="top">270</td>
<td align="center" valign="top">58.62&#x2009;&#x00B1;&#x2009;12.48</td>
<td align="center" valign="top">60.99&#x2009;&#x00B1;&#x2009;12.9</td>
<td align="center" valign="top">164</td>
<td align="center" valign="top">254</td>
</tr>
<tr>
<td align="left" valign="top">Luo</td>
<td align="left" valign="top">SVM</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA and MRA</td>
<td align="center" valign="top">148</td>
<td align="center" valign="top">270</td>
<td align="center" valign="top">58.62&#x2009;&#x00B1;&#x2009;12.48</td>
<td align="center" valign="top">60.99&#x2009;&#x00B1;&#x2009;12.9</td>
<td align="center" valign="top">164</td>
<td align="center" valign="top">254</td>
</tr>
<tr>
<td align="left" valign="top">Luo</td>
<td align="left" valign="top">NN</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA and MRA</td>
<td align="center" valign="top">148</td>
<td align="center" valign="top">270</td>
<td align="center" valign="top">58.62&#x2009;&#x00B1;&#x2009;12.48</td>
<td align="center" valign="top">60.99&#x2009;&#x00B1;&#x2009;12.9</td>
<td align="center" valign="top">164</td>
<td align="center" valign="top">254</td>
</tr>
<tr>
<td align="left" valign="top">Luo</td>
<td align="left" valign="top">Ridge regression</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA and MRA</td>
<td align="center" valign="top">105</td>
<td align="center" valign="top">221</td>
<td align="center" valign="top">/</td>
<td align="center" valign="top">/</td>
<td align="center" valign="top">/</td>
<td align="center" valign="top">/</td>
</tr>
<tr>
<td align="left" valign="top">Luo</td>
<td align="left" valign="top">SVM</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA and MRA</td>
<td align="center" valign="top">105</td>
<td align="center" valign="top">221</td>
<td align="center" valign="top">/</td>
<td align="center" valign="top">/</td>
<td align="center" valign="top">/</td>
<td align="center" valign="top">/</td>
</tr>
<tr>
<td align="left" valign="top">Luo</td>
<td align="left" valign="top">NN</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA and MRA</td>
<td align="center" valign="top">105</td>
<td align="center" valign="top">221</td>
<td align="center" valign="top">/</td>
<td align="center" valign="top">/</td>
<td align="center" valign="top">/</td>
<td align="center" valign="top">/</td>
</tr>
<tr>
<td align="left" valign="top">Ou</td>
<td align="left" valign="top">Model constructed with addition of shape features derived from radiomics</td>
<td/>
<td align="left" valign="top">CTA</td>
<td align="center" valign="top">29</td>
<td align="center" valign="top">93</td>
<td align="center" valign="top">54.20&#x2009;&#x00B1;&#x2009;13.10</td>
<td align="center" valign="top">55.75&#x2009;&#x00B1;&#x2009;10.37</td>
<td align="center" valign="top">50</td>
<td align="center" valign="top">72</td>
</tr>
<tr>
<td align="left" valign="top">Ou</td>
<td align="left" valign="top">Model constructed with further inclusion offirst-order histogram features and second-order texture features</td>
<td/>
<td align="left" valign="top">CTA</td>
<td align="center" valign="top">29</td>
<td align="center" valign="top">93</td>
<td align="center" valign="top">54.20&#x2009;&#x00B1;&#x2009;13.10</td>
<td align="center" valign="top">55.75&#x2009;&#x00B1;&#x2009;10.37</td>
<td align="center" valign="top">50</td>
<td align="center" valign="top">72</td>
</tr>
<tr>
<td align="left" valign="top">Ou</td>
<td align="left" valign="top">Radiomics with clinical info + LASSO regression</td>
<td/>
<td align="left" valign="top">DSA, CTA, and MRA</td>
<td align="center" valign="top">29</td>
<td align="center" valign="top">91</td>
<td align="center" valign="top">54.20&#x2009;&#x00B1;&#x2009;13.10</td>
<td align="center" valign="top">55.75&#x2009;&#x00B1;&#x2009;10.37</td>
<td align="center" valign="top">48</td>
<td align="center" valign="top">72</td>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="left" valign="top">Radiomics morphological feature</td>
<td/>
<td align="left" valign="top">DSA</td>
<td align="center" valign="top">272</td>
<td align="center" valign="top">885</td>
<td align="center" valign="top">54.35&#x2009;&#x00B1;&#x2009;12.20</td>
<td align="center" valign="top">55.50&#x2009;&#x00B1;&#x2009;9.40</td>
<td align="center" valign="top">394</td>
<td align="center" valign="top">763</td>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="left" valign="top">Radiomics morphological feature</td>
<td/>
<td align="left" valign="top">DSA</td>
<td align="center" valign="top">272</td>
<td align="center" valign="top">885</td>
<td align="center" valign="top">54.35&#x2009;&#x00B1;&#x2009;12.20</td>
<td align="center" valign="top">55.50&#x2009;&#x00B1;&#x2009;9.40</td>
<td align="center" valign="top">394</td>
<td align="center" valign="top">763</td>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="left" valign="top">Radiomics morphological feature</td>
<td/>
<td align="left" valign="top">DSA</td>
<td align="center" valign="top">272</td>
<td align="center" valign="top">885</td>
<td align="center" valign="top">54.35&#x2009;&#x00B1;&#x2009;12.20</td>
<td align="center" valign="top">55.50&#x2009;&#x00B1;&#x2009;9.40</td>
<td align="center" valign="top">394</td>
<td align="center" valign="top">763</td>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="left" valign="top">Clinical and radiomics</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">DSA</td>
<td align="center" valign="top">80</td>
<td align="center" valign="top">214</td>
<td align="center" valign="top">55.40&#x2009;&#x00B1;&#x2009;9.73</td>
<td/>
<td align="center" valign="top">84</td>
<td align="center" valign="top">210</td>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="left" valign="top">Clinical and radiomics</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">DSA</td>
<td align="center" valign="top">80</td>
<td align="center" valign="top">214</td>
<td align="center" valign="top">55.40&#x2009;&#x00B1;&#x2009;9.73</td>
<td/>
<td align="center" valign="top">84</td>
<td align="center" valign="top">210</td>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="left" valign="top">Clinical and radiomics</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">DSA</td>
<td align="center" valign="top">80</td>
<td align="center" valign="top">214</td>
<td align="center" valign="top">55.40&#x2009;&#x00B1;&#x2009;9.73</td>
<td/>
<td align="center" valign="top">84</td>
<td align="center" valign="top">210</td>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="left" valign="top">Clinical, morphological, and radiomics</td>
<td/>
<td align="left" valign="top">DSA</td>
<td align="center" valign="top">85</td>
<td align="center" valign="top">273</td>
<td align="center" valign="top">56.84&#x2009;&#x00B1;&#x2009;10.52</td>
<td align="center" valign="top">119</td>
<td align="center" valign="top">239</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="left" valign="top">Clinical, morphological, and radiomics</td>
<td/>
<td align="left" valign="top">DSA</td>
<td align="center" valign="top">85</td>
<td align="center" valign="top">273</td>
<td align="center" valign="top">56.84&#x2009;&#x00B1;&#x2009;10.52</td>
<td align="center" valign="top">119</td>
<td align="center" valign="top">239</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Turhon</td>
<td align="left" valign="top">Clinical, morphological, and radiomics</td>
<td/>
<td align="left" valign="top">DSA</td>
<td align="center" valign="top">85</td>
<td align="center" valign="top">273</td>
<td align="center" valign="top">56.84&#x2009;&#x00B1;&#x2009;10.52</td>
<td align="center" valign="top">119</td>
<td align="center" valign="top">239</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Yamanouchi</td>
<td align="left" valign="top">LASSO (Energy.1 (texture/GLCM)&#x2009;+&#x2009;LLH Variance.1 (texture/GLCM)&#x2009;+&#x2009;LLH ZP (texture/GLSZM))</td>
<td/>
<td align="left" valign="top">MRA</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">35&#x2013;92 (median: 63)</td>
<td align="center" valign="top">9</td>
<td align="center" valign="top">19</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="left" valign="top">Random forest</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA and DSA</td>
<td align="center" valign="top">67</td>
<td align="center" valign="top">106</td>
<td align="center" valign="top">58.37&#x2009;&#x00B1;&#x2009;11.76</td>
<td align="center" valign="top">64.23&#x2009;&#x00B1;&#x2009;13.18</td>
<td align="center" valign="top">75</td>
<td align="center" valign="top">98</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="left" valign="top">Support machine learning</td>
<td/>
<td align="left" valign="top">CTA and DSA</td>
<td align="center" valign="top">67</td>
<td align="center" valign="top">106</td>
<td align="center" valign="top">58.37&#x2009;&#x00B1;&#x2009;11.76</td>
<td align="center" valign="top">64.23&#x2009;&#x00B1;&#x2009;13.18</td>
<td align="center" valign="top">75</td>
<td align="center" valign="top">98</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="left" valign="top">Decision-making tree</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA and DSA</td>
<td align="center" valign="top">67</td>
<td align="center" valign="top">106</td>
<td align="center" valign="top">58.37&#x2009;&#x00B1;&#x2009;11.76</td>
<td align="center" valign="top">64.23&#x2009;&#x00B1;&#x2009;13.18</td>
<td align="center" valign="top">75</td>
<td align="center" valign="top">98</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="left" valign="top">eXtreme gradient Boosting</td>
<td/>
<td align="left" valign="top">CTA and DSA</td>
<td align="center" valign="top">67</td>
<td align="center" valign="top">106</td>
<td align="center" valign="top">58.37&#x2009;&#x00B1;&#x2009;11.76</td>
<td align="center" valign="top">64.23&#x2009;&#x00B1;&#x2009;13.18</td>
<td align="center" valign="top">75</td>
<td align="center" valign="top">98</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="left" valign="top">Gaussian Naive Bayes</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA and DSA</td>
<td align="center" valign="top">67</td>
<td align="center" valign="top">106</td>
<td align="center" valign="top">58.37&#x2009;&#x00B1;&#x2009;11.76</td>
<td align="center" valign="top">64.23&#x2009;&#x00B1;&#x2009;13.18</td>
<td align="center" valign="top">75</td>
<td align="center" valign="top">98</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="left" valign="top">Logistic regression</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA and DSA</td>
<td align="center" valign="top">67</td>
<td align="center" valign="top">106</td>
<td align="center" valign="top">58.37&#x2009;&#x00B1;&#x2009;11.76</td>
<td align="center" valign="top">64.23&#x2009;&#x00B1;&#x2009;13.18</td>
<td align="center" valign="top">75</td>
<td align="center" valign="top">98</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="left" valign="top">K-nearest neighbor</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA and DSA</td>
<td align="center" valign="top">67</td>
<td align="center" valign="top">106</td>
<td align="center" valign="top">58.37&#x2009;&#x00B1;&#x2009;11.76</td>
<td align="center" valign="top">64.23&#x2009;&#x00B1;&#x2009;13.18</td>
<td align="center" valign="top">75</td>
<td align="center" valign="top">98</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="left" valign="top">Bagging classifier</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA and DSA</td>
<td align="center" valign="top">67</td>
<td align="center" valign="top">106</td>
<td align="center" valign="top">58.37&#x2009;&#x00B1;&#x2009;11.76</td>
<td align="center" valign="top">64.23&#x2009;&#x00B1;&#x2009;13.18</td>
<td align="center" valign="top">75</td>
<td align="center" valign="top">98</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="left" valign="top">AdaBoost</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA and DSA</td>
<td align="center" valign="top">67</td>
<td align="center" valign="top">106</td>
<td align="center" valign="top">58.37&#x2009;&#x00B1;&#x2009;11.76</td>
<td align="center" valign="top">64.23&#x2009;&#x00B1;&#x2009;13.18</td>
<td align="center" valign="top">75</td>
<td align="center" valign="top">98</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="left" valign="top">Gradient boosting</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA and DSA</td>
<td align="center" valign="top">67</td>
<td align="center" valign="top">106</td>
<td align="center" valign="top">58.37&#x2009;&#x00B1;&#x2009;11.76</td>
<td align="center" valign="top">64.23&#x2009;&#x00B1;&#x2009;13.18</td>
<td align="center" valign="top">75</td>
<td align="center" valign="top">98</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="left" valign="top">Light gradient boosting Machine</td>
<td/>
<td align="left" valign="top">CTA and DSA</td>
<td align="center" valign="top">67</td>
<td align="center" valign="top">106</td>
<td align="center" valign="top">58.37&#x2009;&#x00B1;&#x2009;11.76</td>
<td align="center" valign="top">64.23&#x2009;&#x00B1;&#x2009;13.18</td>
<td align="center" valign="top">75</td>
<td align="center" valign="top">98</td>
</tr>
<tr>
<td align="left" valign="top">Yang</td>
<td align="left" valign="top">CatBoost</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA and DSA</td>
<td align="center" valign="top">67</td>
<td align="center" valign="top">106</td>
<td align="center" valign="top">58.37&#x2009;&#x00B1;&#x2009;11.76</td>
<td align="center" valign="top">64.23&#x2009;&#x00B1;&#x2009;13.18</td>
<td align="center" valign="top">75</td>
<td align="center" valign="top">98</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="left" valign="top">Radiomics</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA</td>
<td align="center" valign="top">297</td>
<td align="center" valign="top">141</td>
<td align="center" valign="top">55.0 (48.0, 64.3)</td>
<td align="center" valign="top">59.0 (53.0, 69.0)</td>
<td align="center" valign="top">188</td>
<td align="center" valign="top">250</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="left" valign="top">Radiomics-morphological</td>
<td/>
<td align="left" valign="top">CTA</td>
<td align="center" valign="top">297</td>
<td align="center" valign="top">141</td>
<td align="center" valign="top">55.0 (48.0, 64.3)</td>
<td align="center" valign="top">59.0 (53.0, 69.0)</td>
<td align="center" valign="top">188</td>
<td align="center" valign="top">250</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="left" valign="top">Clinical-radiomics-morphological</td>
<td/>
<td align="left" valign="top">CTA</td>
<td align="center" valign="top">297</td>
<td align="center" valign="top">141</td>
<td align="center" valign="top">55.0 (48.0, 64.3)</td>
<td align="center" valign="top">59.0 (53.0, 69.0)</td>
<td align="center" valign="top">188</td>
<td align="center" valign="top">250</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="left" valign="top">Radiomics</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA</td>
<td align="center" valign="top">83</td>
<td align="center" valign="top">72</td>
<td align="center" valign="top">56.0 (51.0, 65.0)</td>
<td align="center" valign="top">65.0 (54.3, 73.0)</td>
<td align="center" valign="top">72</td>
<td align="center" valign="top">83</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="left" valign="top">Radiomics-morphological</td>
<td/>
<td align="left" valign="top">CTA</td>
<td align="center" valign="top">83</td>
<td align="center" valign="top">72</td>
<td align="center" valign="top">56.0 (51.0, 65.0)</td>
<td align="center" valign="top">65.0 (54.3, 73.0)</td>
<td align="center" valign="top">72</td>
<td align="center" valign="top">83</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="left" valign="top">Clinical-radiomics-morphological</td>
<td/>
<td align="left" valign="top">CTA</td>
<td align="center" valign="top">83</td>
<td align="center" valign="top">72</td>
<td align="center" valign="top">56.0 (51.0, 65.0)</td>
<td align="center" valign="top">65.0 (54.3, 73.0)</td>
<td align="center" valign="top">72</td>
<td align="center" valign="top">83</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="left" valign="top">Radiomics</td>
<td align="left" valign="top">/</td>
<td align="left" valign="top">CTA</td>
<td align="center" valign="top">43</td>
<td align="center" valign="top">32</td>
<td align="center" valign="top">57.9 (11.9)</td>
<td align="center" valign="top">67.5 (11.3)</td>
<td align="center" valign="top">34</td>
<td align="center" valign="top">41</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="left" valign="top">Radiomics-morphological</td>
<td/>
<td align="left" valign="top">CTA</td>
<td align="center" valign="top">43</td>
<td align="center" valign="top">32</td>
<td align="center" valign="top">57.9 (11.9)</td>
<td align="center" valign="top">67.5 (11.3)</td>
<td align="center" valign="top">34</td>
<td align="center" valign="top">41</td>
</tr>
<tr>
<td align="left" valign="top">Zhu</td>
<td align="left" valign="top">Clinical-radiomics-morphological</td>
<td/>
<td align="left" valign="top">CTA</td>
<td align="center" valign="top">43</td>
<td align="center" valign="top">32</td>
<td align="center" valign="top">57.9 (11.9)</td>
<td align="center" valign="top">67.5 (11.3)</td>
<td align="center" valign="top">34</td>
<td align="center" valign="top">41</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec15">
<label>3.2</label>
<title>Quality assessment of included studies</title>
<p>The QUADAS-2 tool was used to assess the risk of bias and the RQS was used to assess the quality of each included study. <xref ref-type="fig" rid="fig2">Figure 2</xref> presents the methodological quality evaluation results for the included studies. Overall, the included studies showed high quality, with most exhibiting low or unclear risk of bias. Detailed RQS of each study was presented in <xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Risk of bias and applicability concerns summary.</p>
</caption>
<graphic xlink:href="fnins-18-1474780-g002.tif"/>
</fig>
</sec>
<sec id="sec16">
<label>3.3</label>
<title>Meta-analysis results</title>
<p>The 9 included studies reported 4,284 patients, with 1,411 patients having intracranial aneurysm rupture, resulting in a prevalence of 32.9%. The overall performance of radiomics for predicting intracranial aneurysm rupture showed a combined Sen of 0.78 (95% CI: 0.74&#x2013;0.82), Spe of 0.74 (95% CI: 0.70&#x2013;0.78), +LR of 3.0 (95% CI: 2.7&#x2013;3.4), &#x2212;LR of 0.29 (95% CI: 0.25&#x2013;0.35), and DOR of 10 (95% CI: 9&#x2013;12) (<xref ref-type="fig" rid="fig3">Figure 3</xref>). The overall forest plot revealed significant heterogeneity in both sensitivity and specificity, with <italic>I</italic><sup>2</sup> =&#x2009;90.93% (95% CI: 89.00&#x2013;92.87%) for Sen and <italic>I</italic><sup>2</sup> =&#x2009;94.28% (95% CI: 93.21&#x2013;95.34%) for Spe (<xref ref-type="fig" rid="fig3">Figure 3</xref>). <xref ref-type="fig" rid="fig4">Figure 4</xref> presented the SROC with prediction and confidence contours, yielding an AUC value of 0.83 (95% CI: 0.79&#x2013;0.86).</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>The forest map of the combined sensitivity, specificity of the predictive value of radiomics for intracranial aneurysm rupture.</p>
</caption>
<graphic xlink:href="fnins-18-1474780-g003.tif"/>
</fig>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>SROC curve of radiomics for predicting intracranial aneurysm rupture.</p>
</caption>
<graphic xlink:href="fnins-18-1474780-g004.tif"/>
</fig>
</sec>
<sec id="sec17">
<label>3.4</label>
<title>Publication bias</title>
<p>Deeks&#x2019; test was employed to assess publication bias in the included studies, yielding a <italic>p</italic> value of 0.03. As the <italic>p</italic> value was less than 0.05, it suggested that this meta-analysis was affected by significant publication bias (<xref ref-type="fig" rid="fig5">Figure 5</xref>). After the number of missing published papers was filled by the &#x201C;trim-and-fill method,&#x201D; the results showed that the values of the corresponding variables did not change significantly before and after filling, suggesting that publication bias did not affect the overall effect size of the merger (<xref ref-type="fig" rid="fig6">Figure 6</xref>).</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>Detection of publication bias in predicting intracranial aneurysm rupture using radiomics.</p>
</caption>
<graphic xlink:href="fnins-18-1474780-g005.tif"/>
</fig>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p>Funnel plot of &#x201C;trim-and-fill method&#x201D;.</p>
</caption>
<graphic xlink:href="fnins-18-1474780-g006.tif"/>
</fig>
</sec>
<sec id="sec18">
<label>3.5</label>
<title>Post-test probability</title>
<p>Before the application of radiomics, the pre-test probability of intracranial aneurysm rupture was 33%. The post-test probability of diagnosing ruptured intracranial aneurysms with positive radiomics results was 60%, while negative radiomics results yielded a post-test probability of 13%. When radiomics was positive, the prevalence of ruptured intracranial aneurysms was 60%, and when radiomics was negative, the prevalence was 13% (<xref ref-type="fig" rid="fig7">Figure 7</xref>).</p>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption>
<p>Fagan&#x2019;s Nomogram for predicting intracranial aneurysm rupture using radiomics.</p>
</caption>
<graphic xlink:href="fnins-18-1474780-g007.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="sec19">
<label>4</label>
<title>Discussion</title>
<p>Radiomics and traditional morphological features of intracranial aneurysms are both derived from CTA images but differ in their biological significance and analysis methods. Radiomics features describe the shape and texture characteristics of intracranial aneurysms from a microscopic perspective (<xref ref-type="bibr" rid="ref6">Collins et al., 2015</xref>; <xref ref-type="bibr" rid="ref29">Xu et al., 2019</xref>), while traditional morphological features reflect the macroscopic observation. Radiomics features are three-dimensional, high-throughput biomarkers, but lack biological interpretability. Despite being based on two-dimensional image measurements and containing relatively little information, traditional morphological features remain an important tool for evaluating intracranial aneurysm stability in clinical practice due to their operability and intuitiveness. Numerous studies support the complementary role of combining radiomics and traditional morphological features.</p>
<p>This study combined existing clinical data on the use of radiomics to predict intracranial aneurysm rupture through a systematic review and meta-analysis, obtaining the combined diagnostic efficacy to comprehensively evaluate the predictive value of radiomics. The results suggest that radiomics can be used as an additional tool in assessing the rupture risk of intracranial aneurysms in clinical practice, with a combined Sen of 0.78, Spe of 0.74, +LR of 3.0, &#x2212;LR of 0.29, and DOR of 10. However, considering the significant publication bias in the study conclusions, further research is needed to confirm the predictive value of radiomics for intracranial aneurysm rupture.</p>
<p>Machine learning, a subfield of artificial intelligence, can identify and process complex relationships between multiple variables in large data sets through computer algorithms, applying them to predict unknown data. <xref ref-type="bibr" rid="ref31">Yang et al. (2023)</xref> demonstrated that 12 machine learning models established using radiomics features could predict the risk of intracranial aneurysm rupture in 576 cases (AUC: 0.713&#x2013;0.889), with varying predictive performance among algorithms. The ensemble learning algorithm, particularly the adaptive enhancement model, exhibited the best predictive performance, with an AUC of 0.889 (95% CI: 0.842&#x2013;0.936) in the training set. When the validation set underwent 3-fold cross-validation, repeated 5 times, the AUC of the adaptive enhancement model ranged from 0.842 to 0.918. <xref ref-type="bibr" rid="ref27">Turhon et al. (2023)</xref> analyzed clinical data and DSA images of 1740 patients with intracranial aneurysms, confirming the importance of radiomics in assessing aneurysm rupture risk. The deep learning model, constructed by combining clinical, morphological, and imaging features, significantly outperformed the machine learning model (AUC: 0.878, 95% CI: 0.840&#x2013;0.916) and the traditional Logistic regression model (AUC: 0.849, 95% CI: 0.808&#x2013;0.890) in predicting aneurysm rupture (AUC: 0.929, 95% CI: 0.893&#x2013;0.965; all <italic>p</italic>&#x2009;&#x003C;&#x2009;0.01). The deep learning model&#x2019;s performance was also verified in internal and external data.</p>
<p><xref ref-type="bibr" rid="ref22">Ou et al. (2022)</xref> proposed a self-supervised and pre-trained deep learning model to predict the rupture risk of unruptured intracranial aneurysms in a follow-up of 2&#x2009;years or more. The morphologically aware deep embedding method outperformed the deep learning model trained from scratch and the traditional morphological and imaging genomics models in predicting aneurysm rupture. The study also developed a computer-assisted risk assessment system based on the model. Preliminary tests by 5 neurosurgeons showed that the system could improve their ability to predict intracranial aneurysm rupture and assist in making clinical decisions based on case reasoning. This study overcame the influence of morphological changes before and after aneurysm rupture, enabling the training of deep neural networks with limited data, and has the potential to become an auxiliary tool for clinical intracranial aneurysm rupture risk assessment. <xref ref-type="bibr" rid="ref8">Feng et al. (2023)</xref> first applied a three-dimensional convolutional neural network for automatic detection, segmentation, and morphological measurement of intracranial aneurysms on CTA. Morphological and radiomic features related to aneurysm rupture were input into machine learning models (support vector machines, random forests, and multilayer perceptrons) for training, resulting in a well-performing model on the training and test sets (AUC: 0.85&#x2013;0.90). This method can automatically analyze CTA images of intracranial aneurysms and evaluate their rupture status within 1&#x2009;min, improving clinical work efficiency. Radiomics demonstrates great application potential in assessing intracranial aneurysm stability, and combining machine learning, particularly deep learning, with radiomics is expected to enhance the ability to predict intracranial aneurysm stability.</p>
<p>This study has several limitations. First, most of the included studies are retrospective, which may have potential uncontrollable bias risks. Second, the majority of studies are from Asia, and further research is needed to confirm whether the predictive value of radiomics for intracranial aneurysm rupture can be extended to other regions or countries. Additionally, the numerous and scattered types of radiomics models involved in this study contribute to the significant overall heterogeneity. However, due to data limitations, subgroup analysis based on the model to explore potential sources of heterogeneity could not be performed. The lack of biological interpretability of radiomics is also one of the limitations of this paper, and in order to address the challenge of biological interpretability, future research can focus on combining radiomics with genomic or molecular data to improve the interpretability and clinical relevance of models. Lastly, some studies included in this meta-analysis contained images from external validation populations, obtained by different scanning parameters and machines, which may affect the results and heterogeneity of model validation. In the future, more research is needed to explore the radiomics of different types of aneurysms and to develop models that combine clinical data with radiomics while testing these models in real-world clinical scenarios.</p>
</sec>
<sec sec-type="conclusions" id="sec20">
<label>5</label>
<title>Conclusion</title>
<p>Although the results of this study suggest that radiomics can be used as an auxiliary tool to improve the diagnostic efficacy of ruptured intracranial aneurysms to some extent, the quality of the evidence is limited by significant heterogeneity, potential publication bias, small sample size, and retrospective study design. In the future, more large-scale, prospective, multicenter clinical studies are needed to further evaluate the value of radiomics in predicting intracranial aneurysm rupture.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec21">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">Supplementary material</xref>, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec sec-type="author-contributions" id="sec22">
<title>Author contributions</title>
<p>HW: Conceptualization, Data curation, Formal analysis, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. HX: Software, Supervision, Validation, Writing &#x2013; original draft. JF: Formal analysis, Investigation, Resources, Writing &#x2013; original draft. JL: Investigation, Software, Supervision, Writing &#x2013; original draft. LL: Formal analysis, Investigation, Software, Writing &#x2013; original draft. ZK: Investigation, Software, Validation, Writing &#x2013; original draft. HZ: Data curation, Methodology, Project administration, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="funding-information" id="sec23">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<sec sec-type="COI-statement" id="sec24">
<title>Conflict of interest</title>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="sec25">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec26">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fnins.2024.1474780/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fnins.2024.1474780/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.DOCX" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alwalid</surname> <given-names>O.</given-names></name> <name><surname>Long</surname> <given-names>X.</given-names></name> <name><surname>Xie</surname> <given-names>M.</given-names></name> <name><surname>Yang</surname> <given-names>J.</given-names></name> <name><surname>Cen</surname> <given-names>C.</given-names></name> <name><surname>Liu</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>CT angiography-based Radiomics for classification of intracranial aneurysm rupture</article-title>. <source>Front. Neurol.</source> <volume>12</volume>:<fpage>864</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fneur.2021.619864</pub-id>, PMID: <pub-id pub-id-type="pmid">33692741</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beig</surname> <given-names>N.</given-names></name> <name><surname>Khorrami</surname> <given-names>M.</given-names></name> <name><surname>Alilou</surname> <given-names>M.</given-names></name> <name><surname>Prasanna</surname> <given-names>P.</given-names></name> <name><surname>Braman</surname> <given-names>N.</given-names></name> <name><surname>Orooji</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Perinodular and intranodular radiomic features on lung CT images distinguish adenocarcinomas from granulomas</article-title>. <source>Radiology</source> <volume>290</volume>, <fpage>783</fpage>&#x2013;<lpage>792</lpage>. doi: <pub-id pub-id-type="doi">10.1148/radiol.2018180910</pub-id>, PMID: <pub-id pub-id-type="pmid">30561278</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Lin</surname> <given-names>B.</given-names></name> <name><surname>Zhou</surname> <given-names>J.</given-names></name> <name><surname>Chen</surname> <given-names>L.</given-names></name> <name><surname>Yang</surname> <given-names>Y.</given-names></name> <name><surname>Zhao</surname> <given-names>B.</given-names></name></person-group> (<year>2020</year>). <article-title>Morphological predictors of middle cerebral artery bifurcation aneurysm rupture</article-title>. <source>Clin. Neurol. Neurosurg.</source> <volume>192</volume>:<fpage>105708</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clineuro.2020.105708</pub-id>, PMID: <pub-id pub-id-type="pmid">32058208</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Q.</given-names></name> <name><surname>Xia</surname> <given-names>T.</given-names></name> <name><surname>Zhang</surname> <given-names>M.</given-names></name> <name><surname>Xia</surname> <given-names>N.</given-names></name> <name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>Yang</surname> <given-names>Y.</given-names></name></person-group> (<year>2021</year>). <article-title>Radiomics in stroke neuroimaging: techniques, applications, and challenges</article-title>. <source>Aging Dis.</source> <volume>12</volume>, <fpage>143</fpage>&#x2013;<lpage>154</lpage>. doi: <pub-id pub-id-type="doi">10.14336/AD.2020.0421</pub-id>, PMID: <pub-id pub-id-type="pmid">33532134</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choe</surname> <given-names>J.</given-names></name> <name><surname>Lee</surname> <given-names>S. M.</given-names></name> <name><surname>Do</surname> <given-names>K.-H.</given-names></name> <name><surname>Lee</surname> <given-names>G.</given-names></name> <name><surname>Lee</surname> <given-names>J.-G.</given-names></name> <name><surname>Lee</surname> <given-names>S. M.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Deep learning&#x2013;based image conversion of CT reconstruction kernels improves radiomics reproducibility for pulmonary nodules or masses</article-title>. <source>Radiology</source> <volume>292</volume>, <fpage>365</fpage>&#x2013;<lpage>373</lpage>. doi: <pub-id pub-id-type="doi">10.1148/radiol.2019181960</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname> <given-names>G. S.</given-names></name> <name><surname>Reitsma</surname> <given-names>J. B.</given-names></name> <name><surname>Altman</surname> <given-names>D. G.</given-names></name> <name><surname>Moons</surname> <given-names>K. G. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement</article-title>. <source>Ann. Intern. Med.</source> <volume>162</volume>, <fpage>55</fpage>&#x2013;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.7326/M14-0697</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Etminan</surname> <given-names>N.</given-names></name> <name><surname>Rinkel</surname> <given-names>G. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Unruptured intracranial aneurysms: development, rupture and preventive management</article-title>. <source>Nat. Rev. Neurol.</source> <volume>12</volume>, <fpage>699</fpage>&#x2013;<lpage>713</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrneurol.2016.150</pub-id>, PMID: <pub-id pub-id-type="pmid">27808265</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname> <given-names>J.</given-names></name> <name><surname>Zeng</surname> <given-names>R.</given-names></name> <name><surname>Geng</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>Q.</given-names></name> <name><surname>Zheng</surname> <given-names>Q.</given-names></name> <name><surname>Yu</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Automatic differentiation of ruptured and unruptured intracranial aneurysms on computed tomography angiography based on deep learning and radiomics</article-title>. <source>Insights Imaging</source> <volume>14</volume>:<fpage>423</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13244-023-01423-8</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gillies</surname> <given-names>R. J.</given-names></name> <name><surname>Kinahan</surname> <given-names>P. E.</given-names></name> <name><surname>Hricak</surname> <given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>Radiomics: images are more than pictures, they are data</article-title>. <source>Radiology</source> <volume>278</volume>, <fpage>563</fpage>&#x2013;<lpage>577</lpage>. doi: <pub-id pub-id-type="doi">10.1148/radiol.2015151169</pub-id>, PMID: <pub-id pub-id-type="pmid">26579733</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Greving</surname> <given-names>J. P.</given-names></name> <name><surname>Wermer</surname> <given-names>M. J. H.</given-names></name> <name><surname>Brown</surname> <given-names>R. D.</given-names></name> <name><surname>Morita</surname> <given-names>A.</given-names></name> <name><surname>Juvela</surname> <given-names>S.</given-names></name> <name><surname>Yonekura</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies</article-title>. <source>Lancet Neurol.</source> <volume>13</volume>, <fpage>59</fpage>&#x2013;<lpage>66</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1474-4422(13)70263-1</pub-id>, PMID: <pub-id pub-id-type="pmid">24290159</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname> <given-names>W.</given-names></name> <name><surname>Xiao</surname> <given-names>T.</given-names></name> <name><surname>Jiang</surname> <given-names>X.</given-names></name> <name><surname>Liu</surname> <given-names>Z.</given-names></name> <name><surname>Wang</surname> <given-names>M.</given-names></name> <name><surname>Zheng</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Lymph-vascular space invasion prediction in cervical cancer: exploring radiomics and deep learning multilevel features of tumor and peritumor tissue on multiparametric MRI</article-title>. <source>Biomed. Sig Proc. Control</source> <volume>58</volume>:<fpage>101869</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bspc.2020.101869</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khorrami</surname> <given-names>M.</given-names></name> <name><surname>Jain</surname> <given-names>P.</given-names></name> <name><surname>Bera</surname> <given-names>K.</given-names></name> <name><surname>Alilou</surname> <given-names>M.</given-names></name> <name><surname>Thawani</surname> <given-names>R.</given-names></name> <name><surname>Patil</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features</article-title>. <source>Lung Cancer</source> <volume>135</volume>, <fpage>1</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.lungcan.2019.06.020</pub-id>, PMID: <pub-id pub-id-type="pmid">31446979</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korja</surname> <given-names>M.</given-names></name> <name><surname>Lehto</surname> <given-names>H.</given-names></name> <name><surname>Juvela</surname> <given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Lifelong rupture risk of intracranial aneurysms depends on risk factors: a prospective Finnish cohort study</article-title>. <source>Stroke</source> <volume>45</volume>, <fpage>1958</fpage>&#x2013;<lpage>1963</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.114.005318</pub-id>, PMID: <pub-id pub-id-type="pmid">24851875</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>R.</given-names></name> <name><surname>Zhou</surname> <given-names>P.</given-names></name> <name><surname>Chen</surname> <given-names>X.</given-names></name> <name><surname>Mossa-Basha</surname> <given-names>M.</given-names></name> <name><surname>Zhu</surname> <given-names>C.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name></person-group> (<year>2022</year>). <article-title>Construction and evaluation of multiple Radiomics models for identifying the instability of intracranial aneurysms based on CTA</article-title>. <source>Front. Neurol.</source> <volume>13</volume>:<fpage>876238</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fneur.2022.876238</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindgren</surname> <given-names>A. E.</given-names></name> <name><surname>Koivisto</surname> <given-names>T.</given-names></name> <name><surname>Bj&#x00F6;rkman</surname> <given-names>J.</given-names></name> <name><surname>von und zu Fraunberg</surname> <given-names>M.</given-names></name> <name><surname>Helin</surname> <given-names>K.</given-names></name> <name><surname>J&#x00E4;&#x00E4;skel&#x00E4;inen</surname> <given-names>J. E.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Irregular shape of intracranial aneurysm indicates rupture risk irrespective of size in a population-based cohort</article-title>. <source>Stroke</source> <volume>47</volume>, <fpage>1219</fpage>&#x2013;<lpage>1226</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.115.012404</pub-id>, PMID: <pub-id pub-id-type="pmid">27073241</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Q.</given-names></name> <name><surname>Jiang</surname> <given-names>P.</given-names></name> <name><surname>Jiang</surname> <given-names>Y.</given-names></name> <name><surname>Ge</surname> <given-names>H.</given-names></name> <name><surname>Li</surname> <given-names>S.</given-names></name> <name><surname>Jin</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Prediction of aneurysm stability using a machine learning model based on PyRadiomics-derived morphological features</article-title>. <source>Stroke</source> <volume>50</volume>, <fpage>2314</fpage>&#x2013;<lpage>2321</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.119.025777</pub-id>, PMID: <pub-id pub-id-type="pmid">31288671</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>X.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Liang</surname> <given-names>X.</given-names></name> <name><surname>Yan</surname> <given-names>L.</given-names></name> <name><surname>Chen</surname> <given-names>X.</given-names></name> <name><surname>He</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Prediction of cerebral aneurysm rupture using a point cloud neural network</article-title>. <source>J. Neurointervent Surg.</source> <volume>15</volume>, <fpage>380</fpage>&#x2013;<lpage>386</lpage>. doi: <pub-id pub-id-type="doi">10.1136/neurintsurg-2022-018655</pub-id>, PMID: <pub-id pub-id-type="pmid">35396332</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mackin</surname> <given-names>D.</given-names></name> <name><surname>Fave</surname> <given-names>X.</given-names></name> <name><surname>Zhang</surname> <given-names>L.</given-names></name> <name><surname>Fried</surname> <given-names>D.</given-names></name> <name><surname>Yang</surname> <given-names>J.</given-names></name> <name><surname>Taylor</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Measuring computed tomography scanner variability of radiomics features</article-title>. <source>Investig. Radiol.</source> <volume>50</volume>, <fpage>757</fpage>&#x2013;<lpage>765</lpage>. doi: <pub-id pub-id-type="doi">10.1097/RLI.0000000000000180</pub-id>, PMID: <pub-id pub-id-type="pmid">26115366</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naggara</surname> <given-names>O. N.</given-names></name> <name><surname>White</surname> <given-names>P. M.</given-names></name> <name><surname>Guilbert</surname> <given-names>F.</given-names></name> <name><surname>Roy</surname> <given-names>D.</given-names></name> <name><surname>Weill</surname> <given-names>A.</given-names></name> <name><surname>Raymond</surname> <given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Endovascular treatment of intracranial unruptured aneurysms: systematic review and meta-analysis of the literature on safety and efficacy</article-title>. <source>Radiology</source> <volume>256</volume>, <fpage>887</fpage>&#x2013;<lpage>897</lpage>. doi: <pub-id pub-id-type="doi">10.1148/radiol.10091982</pub-id>, PMID: <pub-id pub-id-type="pmid">20634431</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orru</surname> <given-names>G.</given-names></name> <name><surname>Pettersson-Yeo</surname> <given-names>W.</given-names></name> <name><surname>Marquand</surname> <given-names>A. F.</given-names></name> <name><surname>Sartori</surname> <given-names>G.</given-names></name> <name><surname>Mechelli</surname> <given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Using support vector machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review</article-title>. <source>Neurosci. Biobehav. Rev.</source> <volume>36</volume>, <fpage>1140</fpage>&#x2013;<lpage>1152</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neubiorev.2012.01.004</pub-id>, PMID: <pub-id pub-id-type="pmid">22305994</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ou</surname> <given-names>C.</given-names></name> <name><surname>Chong</surname> <given-names>W.</given-names></name> <name><surname>Duan</surname> <given-names>C.-Z.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Morgan</surname> <given-names>M.</given-names></name> <name><surname>Qian</surname> <given-names>Y.</given-names></name></person-group> (<year>2021</year>). <article-title>A preliminary investigation of radiomics differences between ruptured and unruptured intracranial aneurysms</article-title>. <source>Eur. Radiol.</source> <volume>31</volume>, <fpage>2716</fpage>&#x2013;<lpage>2725</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00330-020-07325-3</pub-id>, PMID: <pub-id pub-id-type="pmid">33052466</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ou</surname> <given-names>C.</given-names></name> <name><surname>Li</surname> <given-names>C.</given-names></name> <name><surname>Qian</surname> <given-names>Y.</given-names></name> <name><surname>Duan</surname> <given-names>C.-Z.</given-names></name> <name><surname>Si</surname> <given-names>W.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Morphology-aware multi-source fusion&#x2013;based intracranial aneurysms rupture prediction</article-title>. <source>Eur. Radiol.</source> <volume>32</volume>, <fpage>5633</fpage>&#x2013;<lpage>5641</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00330-022-08608-7</pub-id>, PMID: <pub-id pub-id-type="pmid">35182202</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Page</surname> <given-names>M. J.</given-names></name> <name><surname>McKenzie</surname> <given-names>J. E.</given-names></name> <name><surname>Bossuyt</surname> <given-names>P. M.</given-names></name> <name><surname>Boutron</surname> <given-names>I.</given-names></name> <name><surname>Hoffmann</surname> <given-names>T. C.</given-names></name> <name><surname>Mulrow</surname> <given-names>C. D.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</article-title>. <source>BMJ</source> <volume>372</volume>:<fpage>n71</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname> <given-names>Y. J.</given-names></name> <name><surname>Yang</surname> <given-names>Z. R.</given-names></name> <name><surname>Sun</surname> <given-names>F.</given-names></name> <name><surname>Zhan</surname> <given-names>S. Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Risk on bias assessment: (6) A Revised Tool for the Quality Assessment on Diagnostic Accuracy Studies (QUADAS-2)</article-title>. <source>Zhonghua Liu Xing Bing Xue Za Zhi</source> <volume>4</volume>, <fpage>524</fpage>&#x2013;<lpage>531</lpage>. doi: <pub-id pub-id-type="doi">10.3760/cma.j.issn.0254-6450.2018.04.028</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spadarella</surname> <given-names>G.</given-names></name> <name><surname>Stanzione</surname> <given-names>A.</given-names></name> <name><surname>Akinci D'Antonoli</surname> <given-names>T.</given-names></name> <name><surname>Andreychenko</surname> <given-names>A.</given-names></name> <name><surname>Fanni</surname> <given-names>S. C.</given-names></name> <name><surname>Ugga</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Systematic review of the radiomics quality score applications: an EuSoMII Radiomics auditing group initiative</article-title>. <source>Eur. Radiol.</source> <volume>33</volume>, <fpage>1884</fpage>&#x2013;<lpage>1894</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00330-022-09187-3</pub-id>, PMID: <pub-id pub-id-type="pmid">36282312</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tomaszewski</surname> <given-names>M. R.</given-names></name> <name><surname>Gillies</surname> <given-names>R. J.</given-names></name></person-group> (<year>2021</year>). <article-title>The biological meaning of radiomic features</article-title>. <source>Radiology</source> <volume>298</volume>, <fpage>505</fpage>&#x2013;<lpage>516</lpage>. doi: <pub-id pub-id-type="doi">10.1148/radiol.2021202553</pub-id>, PMID: <pub-id pub-id-type="pmid">33399513</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turhon</surname> <given-names>M.</given-names></name> <name><surname>Li</surname> <given-names>M.</given-names></name> <name><surname>Kang</surname> <given-names>H.</given-names></name> <name><surname>Huang</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>F.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Development and validation of a deep learning model for prediction of intracranial aneurysm rupture risk based on multi-omics factor</article-title>. <source>Eur. Radiol.</source> <volume>33</volume>, <fpage>6759</fpage>&#x2013;<lpage>6770</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00330-023-09672-3</pub-id>, PMID: <pub-id pub-id-type="pmid">37099175</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vlak</surname> <given-names>M. H. M.</given-names></name> <name><surname>Algra</surname> <given-names>A.</given-names></name> <name><surname>Brandenburg</surname> <given-names>R.</given-names></name> <name><surname>Rinkel</surname> <given-names>G. J. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis</article-title>. <source>Lancet Neurol.</source> <volume>10</volume>, <fpage>626</fpage>&#x2013;<lpage>636</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1474-4422(11)70109-0</pub-id>, PMID: <pub-id pub-id-type="pmid">21641282</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>X.</given-names></name> <name><surname>Zhang</surname> <given-names>H.-L.</given-names></name> <name><surname>Liu</surname> <given-names>Q.-P.</given-names></name> <name><surname>Sun</surname> <given-names>S.-W.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Zhu</surname> <given-names>F.-P.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma</article-title>. <source>J. Hepatol.</source> <volume>70</volume>, <fpage>1133</fpage>&#x2013;<lpage>1144</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jhep.2019.02.023</pub-id>, PMID: <pub-id pub-id-type="pmid">30876945</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamanouchi</surname> <given-names>M.</given-names></name> <name><surname>Arimura</surname> <given-names>H.</given-names></name> <name><surname>Kodama</surname> <given-names>T.</given-names></name> <name><surname>Urakami</surname> <given-names>A.</given-names></name></person-group> (<year>2022</year>). <article-title>Prediction of intracranial aneurysm rupture risk using non-invasive Radiomics analysis based on follow-up magnetic resonance angiography images: a preliminary study</article-title>. <source>Appl. Sci.</source> <volume>12</volume>:<fpage>615</fpage>. doi: <pub-id pub-id-type="doi">10.3390/app12178615</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>B.</given-names></name> <name><surname>Li</surname> <given-names>W.</given-names></name> <name><surname>Wu</surname> <given-names>X.</given-names></name> <name><surname>Zhong</surname> <given-names>W.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Zhou</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Comparison of ruptured intracranial aneurysms identification using different machine learning algorithms and Radiomics</article-title>. <source>Diagnostics</source> <volume>13</volume>:<fpage>627</fpage>. doi: <pub-id pub-id-type="doi">10.3390/diagnostics13162627</pub-id>, PMID: <pub-id pub-id-type="pmid">37627886</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Can</surname> <given-names>A.</given-names></name> <name><surname>Mukundan</surname> <given-names>S.</given-names> <suffix>Jr.</suffix></name> <name><surname>Steigner</surname> <given-names>M.</given-names></name> <name><surname>Castro</surname> <given-names>V. M.</given-names></name> <name><surname>Dligach</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Morphological variables associated with ruptured middle cerebral artery aneurysms</article-title>. <source>Neurosurgery</source> <volume>85</volume>, <fpage>75</fpage>&#x2013;<lpage>83</lpage>. doi: <pub-id pub-id-type="doi">10.1093/neuros/nyy213</pub-id>, PMID: <pub-id pub-id-type="pmid">29850834</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>T. S.</given-names></name> <name><surname>Zhong</surname> <given-names>W. Z.</given-names></name></person-group> (<year>2008</year>). <article-title>Meta-DiSc software in meta-analysis of diagnostic test[J]</article-title>. <source>J. Evid. Based Med.</source> <volume>8</volume>, <fpage>97</fpage>&#x2013;<lpage>108</lpage>.</citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Y.</given-names></name> <name><surname>Xu</surname> <given-names>J.</given-names></name> <name><surname>Liu</surname> <given-names>Q.</given-names></name> <name><surname>Li</surname> <given-names>C.</given-names></name> <name><surname>Liu</surname> <given-names>Z.</given-names></name> <name><surname>Wang</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>A radiomics approach with CNN for shear-wave elastography breast tumor classification</article-title>. <source>IEEE Trans. Biomed. Eng.</source> <volume>65</volume>, <fpage>1935</fpage>&#x2013;<lpage>1942</lpage>. doi: <pub-id pub-id-type="doi">10.1109/TBME.2018.2844188</pub-id>, PMID: <pub-id pub-id-type="pmid">29993469</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>D.-Q.</given-names></name> <name><surname>Chen</surname> <given-names>Q.</given-names></name> <name><surname>Xiang</surname> <given-names>Y.-L.</given-names></name> <name><surname>Zhan</surname> <given-names>C.-Y.</given-names></name> <name><surname>Zhang</surname> <given-names>M.-Y.</given-names></name> <name><surname>Chen</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Predicting intraventricular hemorrhage growth with a machine learning-based, radiomics-clinical model</article-title>. <source>Aging</source> <volume>13</volume>, <fpage>12833</fpage>&#x2013;<lpage>12848</lpage>. doi: <pub-id pub-id-type="doi">10.18632/aging.202954</pub-id>, PMID: <pub-id pub-id-type="pmid">33946042</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>D.</given-names></name> <name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Zheng</surname> <given-names>K.</given-names></name> <name><surname>Chen</surname> <given-names>C.</given-names></name> <name><surname>Li</surname> <given-names>Q.</given-names></name> <name><surname>Zhou</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Classifying ruptured middle cerebral artery aneurysms with a machine learning based, radiomics-morphological model: A multicentral study</article-title>. <source>Front. Neurosci.</source> <volume>15</volume>:<fpage>721268</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnins.2021.721268</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>W.</given-names></name> <name><surname>Li</surname> <given-names>W.</given-names></name> <name><surname>Tian</surname> <given-names>Z.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>K.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Stability assessment of intracranial aneurysms using machine learning based on clinical and morphological features</article-title>. <source>Transl. Stroke Res.</source> <volume>11</volume>, <fpage>1287</fpage>&#x2013;<lpage>1295</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12975-020-00811-2</pub-id>, PMID: <pub-id pub-id-type="pmid">32430796</pub-id></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>D.</given-names></name> <name><surname>Zhang</surname> <given-names>M.</given-names></name> <name><surname>Li</surname> <given-names>Q.</given-names></name> <name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>Zhuang</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>Q.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Can perihaematomal radiomics features predict haematoma expansion?</article-title> <source>Clin. Radiol.</source> <volume>76</volume>, <fpage>629.e1</fpage>&#x2013;<lpage>629.e9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.crad.2021.03.003</pub-id></citation></ref>
</ref-list>
</back>
</article>